Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.03B |
| 2 |
Tesla
TSLA
|
+$1.19B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$840M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$589M |
| 5 |
Pinduoduo
PDD
|
+$576M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.43B |
| 2 |
Apple
AAPL
|
+$1.43B |
| 3 |
Amazon
AMZN
|
+$1.25B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.22B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$923M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 10.21% |
| 3 | Financials | 9.5% |
| 4 | Consumer Discretionary | 7.6% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
ACM Research
ACMR
$5.79B
| $2.31M | ﹤0.01% |
234,237
+192,750
| +465% | +$2.08M |
|
|
HES
3152
PUT
DELISTED
Hess
HES
| $2.31M | ﹤0.01% |
69,400
+25,700
| +59% | +$1.39M |
|
3153
PUT
VanEck Oil Services ETF
OIH
$1.84B
| $2.31M | ﹤0.01% |
28,750
-101,045
| -78% | -$18.8M |
|
3154
PUT
Zymeworks
ZYME
$1.67B
| $2.31M | ﹤0.01% |
+65,000
| New | +$2.66M |
|
|
ACRE
3155
Ares Commercial Real Estate
ACRE
$270M
| $2.31M | ﹤0.01% |
329,737
+143,918
| +77% | +$2.04M |
|
3156
Denali Therapeutics
DNLI
$3.97B
| $2.3M | ﹤0.01% |
131,365
+30,578
| +30% | +$638K |
|
|
ACB
3157
Aurora Cannabis
ACB
$185M
| $2.3M | ﹤0.01% |
21,121
+11,009
| +109% | +$1.97M |
|
3158
Grupo Aeroportuario del Sureste
ASR
$8.3B
| $2.29M | ﹤0.01% |
24,356
-105,774
| -81% | -$17.9M |
|
3159
CALL
Teva Pharmaceuticals
TEVA
$41.2B
| $2.29M | ﹤0.01% |
+255,300
| New | +$2.62M |
|
3160
National Presto Industries
NPK
$989M
| $2.29M | ﹤0.01% |
32,359
-60,570
| -65% | -$5.1M |
|
3161
Vericel Corp
VCEL
$2.31B
| $2.29M | ﹤0.01% |
249,181
-183,957
| -42% | -$2.76M |
|
|
GTHX
3162
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $2.28M | ﹤0.01% |
207,278
+33,526
| +19% | +$626K |
|
|
MAXR
3163
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $2.28M | ﹤0.01% |
213,377
+33,344
| +19% | +$521K |
|
3164
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.33B
| $2.28M | ﹤0.01% |
+244,204
| New | +$2.81M |
|
|
HIO
3165
Western Asset High Income Opportunity Fund
HIO
$340M
| $2.28M | ﹤0.01% |
540,515
+494,113
| +1,065% | +$2.37M |
|
|
NBLX
3166
DELISTED
Noble Midstream Partners LP
NBLX
| $2.27M | ﹤0.01% |
649,944
-440,036
| -40% | -$7.36M |
|
3167
Qfin Holdings
QFIN
$1.61B
| $2.27M | ﹤0.01% |
283,841
-38,100
| -12% | -$326K |
|
|
TRST
3168
Trustco Bank Corp NY
TRST
$938M
| $2.27M | ﹤0.01% |
83,962
-40,599
| -33% | -$1.47M |
|
|
BRFS
3169
DELISTED
BRF SA
BRFS
| $2.26M | ﹤0.01% |
778,504
+319,520
| +70% | +$2.01M |
|
3170
Advanced Drainage Systems
WMS
$10.9B
| $2.25M | ﹤0.01% |
76,624
-54,933
| -42% | -$2.22M |
|
3171
PUT
IQVIA
IQV
$39.3B
| $2.25M | ﹤0.01% |
+20,900
| New | +$2.99M |
|
3172
CEVA Inc
CEVA
$1.08B
| $2.25M | ﹤0.01% |
90,379
-2,142
| -2% | -$59.4K |
|
3173
Vident US Equity Strategy ETF
VUSE
$691M
| $2.25M | ﹤0.01% |
100,000
| – | – |
|
3174
Black Diamond Therapeutics
BDTX
$112M
| $2.25M | ﹤0.01% |
+90,037
| New | +$2.74M |
|
3175
Agilysys
AGYS
$3.06B
| $2.24M | ﹤0.01% |
134,368
+44,442
| +49% | +$1.22M |
|
Similar funds
Goldman Sachs's Q1 2020 Portfolio in Review
As of Q1 2020, Goldman Sachs held 5,784 positions worth $284B, down 28% from $393B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs withdrew a net $27.9B in Q1 2020, closing 606 positions and reducing 2,198 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $731M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Vertiv worth $138M.
- Goldman Sachs's largest Q1 2020 buy was Vertiv: 15,967,049 shares worth $138M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $4.03B increase.
- Goldman Sachs's biggest Q1 2020 reduction was Microsoft, cutting an estimated $2.43B.
- Goldman Sachs fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $731M.
- Goldman Sachs's ten largest holdings make up 18% of its $284B portfolio in Q1 2020.
- Goldman Sachs opened 600 new positions and closed 606 in Q1 2020.
- Goldman Sachs's portfolio value fell 28% quarter-over-quarter to $284B.
Based on Goldman Sachs's 13F filing for Q1 2020, filed 15 May 2020.